MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The phenotypic spectrum and assessment of severity in patients of Spinocerebellar Ataxia-12.

    V. Mathur, A. Shetty, P. Wadia (Jaipur, India)

    Objective: To describe clinical phenotype, manifestations, and assess tremor severity using standard rating scale in genetically confirmed patients with SCA12. Background: Spinocerebellar Ataxia-12 (SCA12) occurs…
  • 2023 International Congress

    Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease

    A. Regalado Mustafá, D. Aguila Godinez, A. Herrera Ruiz, E. Santiago-de-La-Cruz, L. Lira Juárez, M. Medrano Delgado, M. Ruiz Mafud, A. Hernández-Medrano, D. Romero-Terán, M. Medina-Pérez, G. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Domínguez García, J. García Hernández, A. Alcocer Salas, K. Talavera Lagunas (Mexico City, Mexico)

    Objective: Investigate the relationship between the dose of dopamine replacement therapy (DRT) and pain severity as measured by the King's Parkinson's Disease Pain Scale (KPPS)…
  • 2023 International Congress

    Impact of non-pharmacological strategies on progression in Parkinson’s Disease and Cognitive Impairment.

    MAG. Medrano-Delgado, DR. Aguila-Godinez, MF. Ruiz-Mafud, LG. Lira-Juárez, EC. Santiago Delacruz, A. Domínguez-García, AJ. Hernández-Medrano, AY. Regalado-Mustafá, MF. Medina-Pérez, G. Hernandez-Armesto, K. Talavera-Laguna, A. Herrera-Ruiz, J. García-Hernández, DP. Romero-Terán, A. Alcocer-Salas, G. Cerda-Hernández, A. Abundes-Corona, M. Rodríguez-Violante, A. Cervantes-Arriaga (Ciudad de Mexico, Mexico)

    Objective: to determine the Impact of non-pharmacological strategies on progression in Parkinson's Disease and Cognitive Impairment. Background: PD is the second most common neurodegenerative disorder,…
  • 2023 International Congress

    Functional Neuroimaging and Follow up trends in Drug induced movement disorders.

    V. Mathur, A. Shetty, H. Shah, V. Lele, P. Wadia (Jaipur, India)

    Objective: To analyse the role of presynaptic dopaminergic imaging (TRODAT/ F Dopa PET) scans to predict long-term outcomes in patients of new onset parkinsonian symptoms…
  • 2023 International Congress

    Alterations of the Right Olfactory Orbitofrontal Cortex and olfactory impairment in Parkinson’s Disease

    L. Pesantez Pacheco, M. Saquib, D. Ehrlich, M. Hallett, S. Horovitz (Bethesda, USA)

    Objective: To explore the potential role of the right olfactory orbitofrontal cortex in olfactory dysfunction (OD) in Parkinson’s Disease (PD). Background: The orbitofrontal cortex (OFC)…
  • 2023 International Congress

    Sleep disorders and their relationship to non-motor symptoms in Mexican Parkinson’s disease patients

    D. Aguila-Godinez, A. Herrera Ruiz, E. Santiago, L. Lira Juarez, MA. Medrano Delgado, M. Ruiz Mafud, A. Hernandez-Medrano, A. Regalado Mustafa, G. Cerda Hernandez, M. Rodriguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Dominguez Garcia, D. Romero-Teran, K. Talvera-Lagunas, M. Medina Perez (Mexico City, Mexico)

    Objective: Analyze the impact of sleep disorders (SD) on the severity of non-motor symptoms (NMS) in Parkinson’s Disease (PD) patients Background: Sleep is a physiological…
  • 2023 International Congress

    Olfactory and taste function in early Parkinson’s disease with mild cognitive impairment

    JJ. Lee, IH. Kwak, HI. Ma, YE. Kim (Anyang-si, Republic of Korea)

    Objective: The purpose of this study was to compare olfactory and taste function between early drug-naive Idiopathic Parkinson's disease (IPD) patients with or without mild…
  • 2023 International Congress

    Safety and performance of DBS primary cell IPG replacement: An interim report from the ADROIT study

    S. Groppa, J. Muñoz, K. Ashkan, A. Gharabaghi, T. Tomlinson, M. Frassica, M. Navas Garcia (Mainz, Germany)

    Objective: To present procedure-related safety of DBS IPG battery replacements and variations of therapeutic performance within the ADROIT post-market study. Background: DBS implantable pulse generator…
  • 2023 International Congress

    Spinal cord stimulation for gait in Parkinsons disease in subthreshold settings

    R. Carra, J. Menezes, K. Duarte, M. Teixeira, E. Barbosa, R. Cury (Sao Paulo, Brazil)

    Objective: To assess optimal parameters for tonic spinal cord stimulation (SCS) for Parkinson’s Disease (PD) gait disorders in blinded settings. Background: SCS is a promising…
  • 2023 International Congress

    Deep brain stimulation modulates subthalamic beta bursts related to movement velocity adjustments in Parkinson’s disease

    M. Bange, G. Gonzalez-Escamilla, DM. Herz, G. Tinkhauser, M. Glaser, D. Ciolac, H. Tan, P. Brown, S. Groppa (Mainz, Germany)

    Objective: The aim of this study was to investigate the role of subthalamic beta bursts for dynamic control of precise drawing movements. Background: The performance…
  • « Previous Page
  • 1
  • …
  • 522
  • 523
  • 524
  • 525
  • 526
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley